Analytical Methodologies for the Stereoselective Determination of Sibutramine: An Overview

1. Luque CA, Rey JA - The discovery and status of sibutramine as an antiobesity drug. Eur J Pharmacol. 2002;(2-3):119-128.10.1016/S0014-2999(02)01423-1Search in Google Scholar

2. Finer N. - Sibutramine: its mode of action and efficacy. Int J Obes Relat Metab Disord. 2002;26(4):29-33.10.1038/sj.ijo.0802216Search in Google Scholar

3. Nisoli E, Carruba MO - An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action. Obes Rev. 2000;1(2):127-139.10.1046/j.1467-789x.2000.00020.xSearch in Google Scholar

4. Bodhankar SL, Thakurdesai PA, Singhal S, et al. - Anorexic effect of (R)-sibutramine: comparison with (RS)-sibutramine and (S)-sibutramine. Indian J Physiol Pharmacol. 2007;51(2):175-178.Search in Google Scholar

5. Filippatos TD, Kiortsis DN, Liberopoulos EN, et al. - A review of the metabolic effects of sibutramine. Curr Med Res Opin. 2005;21(3):457-468.10.1185/030079905X38132Search in Google Scholar

6. Glick SD, Haskew RE, Maisonneuve IM, et al. - Enantioselective behavioral effects of sibutramine metabolites. Eur J Pharmacol. 2000;397:93-102.10.1016/S0014-2999(00)00216-8Search in Google Scholar

7. Noh K, Bae K, Min B, et al. - Enantioselective pharmacokinetics of sibutramine in rat. Arch Pharm Res. 2010;33:267-273.10.1007/s12272-010-0212-720195828Search in Google Scholar

8. Tyczynski JE, Oleske DM, Klingman D, et al. - Safety assessment of an anti-obesity drug (sibutramine): a retrospective cohort study. Drug Saf. 2012;35(8):629-644.10.1007/BF0326196022788234Search in Google Scholar

9. Maggioni AP, Caterson ID, Urso R, et al. - Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trial. J Cardiovasc Med. 2017;18(3):144-151.10.2459/JCM.000000000000049228002198Search in Google Scholar

10. Scheen AJ - Cardiovascular risk-benefit profile of sibutramine. Am J Cardiovasc Drugs. 2010; 10(5):321-334.10.2165/11584800-000000000-0000020860415Search in Google Scholar

11. Dunn JD, Gryniewicz-Ruzicka CM, Kauffman JF, et al.- Using a portable ion mobility spectrometer to screen dietary supplements for sibutramine. J Pharm Biomed Anal. 2011; 54(3):469-474.10.1016/j.jpba.2010.09.01720940091Search in Google Scholar

12. Diefenbach IC, Friedrich M, Dos Santos MR, et al. - Development and validation of a column high-performance liquid chromatographic method for determination of sibutramine in capsules. J AOAC Int. 2009; 92(1):148-151.10.1093/jaoac/92.1.148Search in Google Scholar

13. Rebiere H, Guinot P, Civade C, et al. - Detection of hazardous weightloss substances in adulterated slimming formulations using ultra-highpressure liquid chromatography with diode-array detection. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(2):161-171.10.1080/19440049.2011.638676Search in Google Scholar

14. Um SY, Kim KB, Kim SH, et al. - Determination of the active metabolites of sibutramine in rat serum using column-switching HPLC. J Sep Sci. 2008;31(15):2820-2826.10.1002/jssc.200800041Search in Google Scholar

15. Bae JW, Choi CI, Jang CG, et al. - Simultaneous determination of sibutramine and its active metabolites in human plasma by LC-MS/MS and its application to a pharmacokinetic study. Biomed Chromatogr. 2011;25(11):1181-1188.10.1002/bmc.1587Search in Google Scholar

16. Fang QK, Senanayake CH, Han Z, et al. - First preparation of enantiomerically pure sibutramine and its major metabolite, and determination of their absolute configuration by single crystal X-ray analysis. Tetrahedron Asymmetry, 1999; 10:4477-4480.10.1016/S0957-4166(99)00511-XSearch in Google Scholar

17. Han Z, Krishnamurthy D, Pflum D, et al. - First practical synthesis of enantiomerically pure (R)- and (S)-desmethylsibutramine (DMS) and unambiguous determination of their absolute configuration by singlecrystal X-ray analysis. Tetrahedron Asymmetry, 2002;13(2):107-109.10.1016/S0957-4166(02)00086-1Search in Google Scholar

18. Krishnamurthy D, Han Z, Wald SA, et al. - First asymmetric synthesis of (R)-desmethylsibutramine. Tetrahedron Asymmetry, 2002;43(13):2331-2333.10.1016/S0040-4039(02)00297-6Search in Google Scholar

19. Han Z, Krishnamurthy D, Fang QF, et al. - New resolution approach for large-scale preparation of enantiopure didesmethylsibutramine (DDMS). Tetrahedron Asymmetry, 2003;14(22):3533-3536.10.1016/j.tetasy.2003.08.042Search in Google Scholar

20. Bojarski J, Aboun-Enein HY, Ghanem A - What’s new in chromatographic enantioseparations. Curr Anal Chem. 2005;1:59-97.10.2174/1573411052948433Search in Google Scholar

21. Singh AK, Pedro LG, Gomes FP, et al. - Development and validation of sensitive methods for determination of sibutramine hydrochloride monohydrate and direct enantiomeric separation on a protein-based chiral stationary phase. J. AOAC Int. 2008; 91(3):572-579.Search in Google Scholar

22. Radhakrishna T, Lakshmi-Narayana C, Sreenivas-Rao D, et al. - LC method for the determination of assay and purity of sibutramine hydrochloride and its enantiomers by chiral chromatography. J Pharm Biomed Anal. 2000;22:627-639.10.1016/S0731-7085(99)00303-9Search in Google Scholar

23. Bae K, Noh K, Jang K, et al. - Analysis of enantiomers of sibutramine and its metabolites in rat plasma by liquid chromatography-mass spectrometry using a chiral stationary-phase column. J Pharm Biomed Anal. 2009;50(2):267-70.10.1016/j.jpba.2009.04.02419473801Search in Google Scholar

24. Kang W, Bae K, Noh K - Enantioselective determination of sibutramine and its active metabolites in human plasma. J Pharm Biomed Anal. 2009; 51:264-267.Search in Google Scholar

25. Scriba GK - Differentiation of enantiomers by capillary electrophoresis. Top Curr Chem. 2013; 340:209-275.10.1007/128_2013_43823666080Search in Google Scholar

26. Rezanka P, Navrátilová K, Rezanka M, et al. - Application of cyclodextrins in chiral capillary electrophoresis. Electrophoresis. 2014; 35(19):2701-2721.10.1002/elps.20140014524853583Search in Google Scholar

27. Zhu H, Wu E, Chen J, et al. - Enantioseparation and determination of sibutramine in pharmaceutical formulations by capillary electrophoresis. Bull. Korean Chem. Soc. 2010; 31:1496-1500.Search in Google Scholar

28. Lee YJ, Choi S, Lee J, et al. - Chiral discrimination of sibutramine enantiomers by capillary electrophoresis and proton nuclear magnetic resonance spectroscopy. Arch Pharm Sci Res. 2012;35(4):671-681.10.1007/s12272-012-0411-522553060Search in Google Scholar

29. Hancu G, Hilochie A, Vlad RA, et al. - Enantiomeric separation of sibutramine by capillary zone electrophoresis. J Braz Chem Soc. 2016;27(6):1116-1120.Search in Google Scholar

30. Zhu H, Wu E, Chen J, et al. - Reverse migration order of sibutramine enantiomers as a function of cyclodextrin concentration in capillary electrophoresis. J Pharm Biomed Anal. 2011; 54:1007-1112.10.1016/j.jpba.2010.12.00121232897Search in Google Scholar

31. Fang L, Yu J, Jiang Z, et al. - Preparation of a β-cyclodextrin-based open-tubular capillary electrochromatography column and application for enantioseparations of ten basic drugs. PLoS One. 2016; 15(1): e0146292.10.1371/journal.pone.0146292471474726771454Search in Google Scholar